← Back to Cancer ScreeningFDA approved (MRD)
Signatera by Natera
Cancer patients monitoring for recurrence
Variable
Test Performance
Sensitivity
Varies by cancer
Specificity
>99.8%
Detection Method
ctDNA (personalized)
Turnaround
3-7 days
Key Features
Personalized cancer monitoring • Detects recurrence early • Treatment response tracking • Tumor-informed approach
Who It's For
Important Notes
Not for initial detection - used for monitoring known cancer patients. Very high specificity for recurrence.
Learn more about Signatera by Natera
Discuss with your physician before ordering.
Visit Signatera by NateraCompare All